Literature DB >> 11528568

Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses.

T R Sterling1, S E Dorman, R E Chaisson, L Ding, J Hackman, K Moore, S M Holland.   

Abstract

Extrapulmonary tuberculosis is presumably a marker of underlying immunodeficiency, but cytokine response pathways in these patients have not been well studied. Cytokine responses of peripheral blood mononuclear cells from human immunodeficiency virus-seronegative adults with prior culture-confirmed extrapulmonary tuberculosis were compared with those of persons with latent Mycobacterium tuberculosis infection. Mitogen-stimulated interferon (IFN)-gamma production, interleukin (IL)-12 production, and IFN-gamma receptor- and IL-12 receptor-mediated cytokine production did not differ between case patients and control patients. However, median resting IL-8 production was significantly lower in case patients than control patients (8051 vs. 19,290 pg/mL; P=.009). In addition, the median tumor necrosis factor (TNF)-alpha response was lower in case patients than control patients after stimulation with lipopolysaccharide (833 vs. 1149 pg/mL; P=.06) and lipopolysaccharide plus IFN-gamma (3301 vs. 4411 pg/mL; P=.04). These abnormalities in resting IL-8 and lipopolysaccharide-induced TNF-alpha production were not associated with IFN-gamma or IL-12 abnormalities and were detected up to several years after cure of disease, suggesting an abnormality in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528568     DOI: 10.1086/322670

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

1.  Site of extrapulmonary tuberculosis is associated with HIV infection.

Authors:  Ira L Leeds; Matthew J Magee; Ekaterina V Kurbatova; Carlos del Rio; Henry M Blumberg; Michael K Leonard; Colleen S Kraft
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

2.  The impact of IFN-γ receptor on SLPI expression in active tuberculosis: association with disease severity.

Authors:  Nancy L Tateosian; Virginia Pasquinelli; Rodrigo E Hernández Del Pino; Nella Ambrosi; Diego Guerrieri; Sigifredo Pedraza-Sánchez; Natalia Santucci; Luciano D'Attilio; Joaquín Pellegrini; María A Araujo-Solis; Rosa M Musella; Domingo J Palmero; Rogelio Hernandez-Pando; Verónica E Garcia; H Eduardo Chuluyan
Journal:  Am J Pathol       Date:  2014-03-04       Impact factor: 4.307

3.  Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis.

Authors:  Alexandre S de Almeida; Christina T Fiske; Timothy R Sterling; Spyros A Kalams
Journal:  Clin Vaccine Immunol       Date:  2011-10-28

4.  Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis.

Authors:  Christina T Fiske; Alexandre S de Almeida; Ayumi K Shintani; Spyros A Kalams; Timothy R Sterling
Journal:  Clin Vaccine Immunol       Date:  2012-06-06

5.  Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits.

Authors:  Susan E Dorman; Christine L Hatem; Sandeep Tyagi; Katherine Aird; Javier Lopez-Molina; M Louise M Pitt; Bernard C Zook; Arthur M Dannenberg; William R Bishai; Yukari C Manabe
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

6.  Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis.

Authors:  Alison A Motsinger-Reif; Paulo R Z Antas; Noffisat O Oki; Shawn Levy; Steven M Holland; Timothy R Sterling
Journal:  BMC Med Genet       Date:  2010-03-02       Impact factor: 2.103

Review 7.  Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis.

Authors:  Cho Naing; Joon Wah Mak; Mala Maung; Shew Fung Wong; Ani Izzuani Binti Mohd Kassim
Journal:  Lung       Date:  2012-11-23       Impact factor: 2.584

8.  Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.

Authors:  Rosalind Rowland; Ansar A Pathan; Iman Satti; Ian D Poulton; Magali M L Matsumiya; Megan Whittaker; Angela M Minassian; Geraldine A O'Hara; Matthew Hamill; Janet T Scott; Stephanie A Harris; Hazel C Poyntz; Cynthia Bateman; Joel Meyer; Nicola Williams; Sarah C Gilbert; Alison M Lawrie; Adrian V S Hill; Helen McShane
Journal:  Hum Vaccin Immunother       Date:  2012-11-10       Impact factor: 3.452

9.  Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.

Authors:  Timothy Lahey; Mecky Matee; Lillian Mtei; Muhammad Bakari; Kisali Pallangyo; C Fordham von Reyn
Journal:  BMC Infect Dis       Date:  2009-02-23       Impact factor: 3.090

10.  Black race, sex, and extrapulmonary tuberculosis risk: an observational study.

Authors:  Christina T Fiske; Marie R Griffin; Holt Erin; Jon Warkentin; Kaltenbach Lisa; Patrick G Arbogast; Timothy R Sterling
Journal:  BMC Infect Dis       Date:  2010-01-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.